US FDA expands approval to GSK’s Arexvy for adults aged 50-59, at increased risk
The RSV vaccine adjuvanted is currently approved for use in adults aged 60 and older and recommended by CDC/ACIP using shared…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.